CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd

BSE 524742 CAPLIPOINT INE475E01026
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 60 trading days

11 filings · 6 material · busiest 2026-08-12

What it files

Analyst / Investor Meet2 General1 Concall Transcript1 Board Outcome1 Dividend1 Results1 Change in Management1 Investor Presentation1

Filings

11 in the window

  1. 21 August 2026

    General

    General Updates

    Completion of Unannounced USFDA Inspection at the facility of Caplin Steriles Limited (Company's subsidiary)

    Company Update / General View filing →

  2. 19 August 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript for Earnings call- Q1- FY 2026-27

    Company Update / Earnings Call Transcript View filing →

  3. 12 August 2026

    Board Outcome

    Board Meeting Outcome for Meeting Held On August 12, 2026

    Board meeting outcome for meeting held on August 12, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  4. 12 August 2026

    Dividend

    Corporate Action-Board approves Dividend

    Record date for Final Dividend is September 18, 2026

    Corp. Action / Dividend View filing →

  5. 12 August 2026

    Results

    Results For Quarter Ended June 30, 2026

    Financial Results for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  6. 12 August 2026

    Change in Management

    Change in Management

    The Board of Director in its meeting held today, August 12, 2026, approved the appointment of directors.

    Company Update / Change in Management View filing →

  7. 12 August 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation for the Earnings Call for the Quarter ended June 30, 2026.

    Company Update / Investor Presentation View filing →

  8. 12 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording of Earnings call for the Quarter ended June 30, 2026

    Company Update / Analyst / Investor Meet View filing →

  9. 30 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Post-results conference call invite for the quarter ended June 30, 2026 is enclosed herewith.

    Company Update / Analyst / Investor Meet View filing →

  10. 29 July 2026

    Board Meeting

    Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend, If Any.

    Caplin Point Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1. Unaudited financial ....

    Board Meeting / Board Meeting View filing →

  11. 22 June 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement for transfer of Unclaimed dividend and shares to IEPF

    Company Update / Newspaper Publication View filing →